Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency

There is no fulltext present in this item.

Title:	Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency
Author(s):	Kuilenburg, A.B.P. van; Vreken, P.; Abeling, N.G.G.M.; Bakker, H.; Meinsma, R.; Lenthe, G.H. van ; Abreu, R.A. de ; Smeitink, J.A.M. ; Kayserili, H.; Apak, M.Y.; Christensen, E.; Holopainen, I.; Pulkki, K.; Riva, D.; Botteon, G.; Holme, E.; Tulinius, M.; Kleijer, W.J.; Beemer, F.A.; Duran, M.; Niezen-Koning, K.E.; Smit, G.P.; Jakobs, C.; Smit, L.M.E.; Moog, U.; Spaapen, L.J.; Gennip, A.H. van
Publication year:	1999
Source:	Human Genetics, vol. 104, (1999), pp. 1-9
Number of Pages:	9 p.
ISSN:	0340-6717
DOI:	https://doi.org/10.1007/PL00008711
Publication type:	Article / Letter to editor
Please use this identifier to cite or link to this item : http://hdl.handle.net/2066/184782
Display more details
Subject:	Inborn errors of metabolism Prognostic significance of drug metabolism, and doctors' and patients' compliance during maintenance treatment with methotrexate and 6-mercaptopurine in childhood acute lymphoblastic leukemia. Erfelijke stofwisselingsziekten Prognostische betekenis van metabolisme en compliance van arts en patiënt gedurende onderhoudsbehandeling met methotrexaat en 6-mercaptopurine bij kinderen met acute lymfatische leukemie.
Organization:	Orthopaedics Paediatrics
Journal title:	Human Genetics
Volume:	vol. 104
Page start:	p. 1
Page end:	p. 9